As we age, our NAD+ levels naturally decline, leading to fatigue, cognitive decline, and a weakened immune system
The safe alternative options include tirzepatide (a dual agonist), Rybelsus (an oral pill), or classic appetite suppressants
227 In -cells, increased cAMP affects glucagon synthesis and release
Subsequently, reduced inflammation was achieved via administration of NLY01, a GLP-1RA, resulting in lower levels of RGC death and astrogliosis
Thats accurate, but it leaves out the bigger picture: this program does nothing for the tens of millions of American adults under 65 who are also managing weight and metabolic health, and who have no path to $50-a-month GLP-1 coverage through this Bridge
Interesting that FDA medical officers found none of the seven peptides met the 503A criteria